TipRanks
Advertisement
Advertisement

DE:XIN Stock Latest News

Shandong Xinhua Pharma Proposes Board Appointment of Senior Economist Liu Weimin
Company AnnouncementsShandong Xinhua Pharma Proposes Board Appointment of Senior Economist Liu Weimin
1h ago
Xinhua Pharmaceutical Wins Approval for Sacubitril Valsartan Tablets in China
PremiumCompany Announcements
Xinhua Pharmaceutical Wins Approval for Sacubitril Valsartan Tablets in China
1d ago
Shandong Xinhua Subsidiary Wins Approval for Donepezil Orally Disintegrating Tablets in China
PremiumCompany Announcements
Shandong Xinhua Subsidiary Wins Approval for Donepezil Orally Disintegrating Tablets in China
21d ago
Shandong Xinhua Pharmaceutical Wins Approval for New Oral Solution
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Wins Approval for New Oral Solution
21d ago
Shandong Xinhua Pharma Wins Approval for Levocarnitine Oral Solution
PremiumCompany Announcements
Shandong Xinhua Pharma Wins Approval for Levocarnitine Oral Solution
21d ago
Shandong Xinhua Subsidiary Wins Key Generic Consistency Approval for Azithromycin
PremiumCompany AnnouncementsShandong Xinhua Subsidiary Wins Key Generic Consistency Approval for Azithromycin
1M ago
Shandong Xinhua Wins NMPA Approval for Dapoxetine Tablets
Premium
Company Announcements
Shandong Xinhua Wins NMPA Approval for Dapoxetine Tablets
1M ago
Shandong Xinhua Pharmaceutical Releases Unaudited 2026 Interim Results
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Releases Unaudited 2026 Interim Results
2M ago
Xinhua Pharmaceutical Wins China Approval for Dapagliflozin Tablets
PremiumCompany Announcements
Xinhua Pharmaceutical Wins China Approval for Dapagliflozin Tablets
2M ago
Shandong Xinhua Pharmaceutical Schedules Board Meeting to Review 2026 Interim Results
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Schedules Board Meeting to Review 2026 Interim Results
2M ago
Shandong Xinhua Pharmaceutical Declares 2025 Final Dividend and Clarifies Tax Arrangements
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Declares 2025 Final Dividend and Clarifies Tax Arrangements
4M ago
Shandong Xinhua Pharmaceutical Shareholders Approve All AGM Resolutions and 2025 Dividend Plan
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Shareholders Approve All AGM Resolutions and 2025 Dividend Plan
4M ago
Xinhua Pharmaceutical Wins Approval to Begin Clinical Trials for Novel Pain Drug LXH-2103
PremiumCompany AnnouncementsXinhua Pharmaceutical Wins Approval to Begin Clinical Trials for Novel Pain Drug LXH-2103
4M ago
Shandong Xinhua Pharmaceutical Wins China Approval for Sevelamer Carbonate Suspension
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Wins China Approval for Sevelamer Carbonate Suspension
4M ago
Shandong Xinhua Pharmaceutical Sets AGM to Review 2025 Results and Governance Changes
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Sets AGM to Review 2025 Results and Governance Changes
5M ago
Xinhua Pharmaceutical’s Phenobarbital Tablets Clear China’s Generic Consistency Evaluation
PremiumCompany Announcements
Xinhua Pharmaceutical’s Phenobarbital Tablets Clear China’s Generic Consistency Evaluation
5M ago
Shandong Xinhua Pharmaceutical Wins NMPA Approval for New Ambroxol–Clenbuterol Oral Solution
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Wins NMPA Approval for New Ambroxol–Clenbuterol Oral Solution
5M ago
Shandong Xinhua Pharmaceutical Wins NMPA Approval for Benserazide Hydrochloride API
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Wins NMPA Approval for Benserazide Hydrochloride API
5M ago
Shandong Xinhua Pharma Q1 Profit Drops Despite Stable Revenue and Asset Base
PremiumCompany Announcements
Shandong Xinhua Pharma Q1 Profit Drops Despite Stable Revenue and Asset Base
5M ago
Xinhua Pharmaceutical Secures Approval to Take Over Potassium Chloride Granules Marketing Rights
PremiumCompany AnnouncementsXinhua Pharmaceutical Secures Approval to Take Over Potassium Chloride Granules Marketing Rights
6M ago
Shandong Xinhua Pharmaceutical Wins NMPA Approval for Bumetanide Injection
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Wins NMPA Approval for Bumetanide Injection
6M ago
Shandong Xinhua Pharma Sets Board Meeting to Review Q1 2026 Results
Premium
Company Announcements
Shandong Xinhua Pharma Sets Board Meeting to Review Q1 2026 Results
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >